Effects of phosphodiesterase-4 inhibitor on the mucin secretion in airway stimulated with acrolein: Experiment with rats

National Medical Journal of China

Volumn 88, Issue 42, 2008, Pages 2988-2993

  Wang, Xun ^a   Li, Ji Qiong ^a   Chen, Lei ^a   Wang, Hai Xia ^a   Sun, Bei Bei ^a   Wang, Tao ^a   Xu, Dan ^a   Wen, Fu Qiang ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

Acrolein; Mucins; Phosphodiesterase inhibitors; Rats, Sprague Dawley; Respiratory mucosa

Indexed keywords

4 (3 CHLOROPHENYL) 1,7 DIETHYLPYRIDO[2,3 D]PYRIMIDIN 2(1H) ONE; ACROLEIN; ALCIAN BLUE; CYTOKINE INDUCED NEUTROPHIL CHEMOATTRACTANT; MESSENGER RNA; METHYLCELLULOSE; MUCIN 5AC; TUMOR NECROSIS FACTOR ALPHA; MUCIN; PHOSPHODIESTERASE INHIBITOR; PYRIDINE DERIVATIVE; PYRIMIDINONE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL COUNT; CONTROLLED STUDY; DRUG EFFICACY; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMUNOHISTOCHEMISTRY; LUNG LAVAGE; MUCUS SECRETION; NONHUMAN; OPTICAL DENSITY; PERIODIC ACID SCHIFF STAIN; PROTEIN EXPRESSION; RAT; RESPIRATORY TRACT MUCOSA; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING; ANIMAL; DRUG EFFECT; MALE; SECRETION; SPRAGUE DAWLEY RAT;

ACROLEIN; ANIMALS; MALE; MUCINS; PHOSPHODIESTERASE INHIBITORS; PYRIDINES; PYRIMIDINONES; RATS; RATS, SPRAGUE-DAWLEY; RESPIRATORY MUCOSA;

EID: 77954833734     PISSN: 03762491     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Mata M, Ruíz A, Cerdá M, et al. Oral N-acetylcysteine reduces bleomycin-induced lung damage and mucin Muc5ac expression in rats. Eur Respir J, 2003, 22: 900-905. (Pubitemid 37540639)
2. Borchers MT, Vert SE, Leikauf GD. Acrolein-induced MUC5ac expression in rat airways. Am J Physiol, 1998, 274:L573-581.
3. Chorley BN, Crews AL, Li Y, et al. Differential Muc2 and Muc5ac secretion by stimulated guinea pig tracheal epithelial cells in vitro. Respir Res, 2006, 7:35.
4. Song JS, Cho KS, Yoon HK, et al. Neutrophil elastase causes MUC5AC mucin synthesis via EGF receptor, ERK and NF-κB pathways in A549 cells. Korean J Intern Med, 2005, 20: 275-283.
5. Karras JG, Crosby JR, Guha M, et al. Anti-inflammatory activity of inhaled IL-4 receptor-alpha antisense oligonucleotide in mice. Am J Respir Cell Mol Biol, 2007, 36: 276-285.
6. Facchinetti F, Amadei F, Geppetti P, et al. Alpha, beta-unsaturated aldehydes in cigarette smoke release inflammatory mediators from human macrophages. Am J Respir Cell Mol Biol, 2007, 37: 617-623.
7. Ramos CD, Heluy-Neto NE, Ribeiro RA, et al. Neutrophil migration induced by IL-8-activated mast cells is mediated by CINC-1. Cytokine, 2003, 21: 214-23.
8. Stevenson CS, Coote K, Webster R, et al. Characterization of cigarette smoke-induced inflammatory and mucus hypersecretory changes in rat lung and the role of CXCR2 ligands in mediating this effect. Am J Physiol Lung Cell Mol Physiol, 2005, 288: 1514-522.
9. Finkelstein EI, Nardini M, van der Vliet A. Inhibition of neutrophil apoptosis by acrolein: a mechanism of tobacco-related lung disease? Am J Physiol Lung Cell Mol Physiol, 2001, 281: L732-739.
10. Kroegel C, Foerster M. Phosphodiesterase-4 inhibitors as a novel approach for the treatment of respiratory disease: cilomilast. Expert Opin Investig Drugs, 2007, 16:109-124.
11. Antoniu SA. Roflumilast for the treatment of chronic obstructive pulmonary disease. Curr Opin Investig Drugs, 2006, 7:412-417. (Pubitemid 43772979)
12. Kobayashi K, Suda T, Manabe H, et al. Administration of PDE4 inhibitors suppressed the pannus-like inflammation by inhibition of cytokine production by macrophages and synovial fibroblast proliferation. Mediators Inflamm, 2007, 2007:58901.
13. Grootendorst DC, Gauw SA, Verhoosel RM, et al. Reduction in sputum neutrophil and eosinophil numbers by the PDE4 inhibitor roflumilast in patients with COPD. Thorax, 2007, 62:1081-1087.